Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
February 17, 2023 at 08:31 AM EST
Even if the FDA grants full approval of the Alzheimer's treatment Leqembi, the rollout of the treatment will take years.
